News
IRISS Has 2 Open Positions on the Board of Directors
As the IRISS Forum continues to grow, the Board of Directors is continuously striving to ensure that members have a strong voice in the future of IRISS. The Board is now seeking nominations for two vacant positions on the Board.
Change in leadership of the Steering Committee
On behalf of the IRISS Forum, we’d like to thank Donald Palmer for his 10 years of volunteer service with the IRISS-Forum. Don has made the difficult decision to step down as the IRISS SC Chair. Moving forward, the IRISS Steering Committee unanimously nominated Kelly Hnat as the new Steering Committee Chair, and to our pleasure, Kelly has accepted the nomination.
Appointment of David Berglund and Jake Doran to the Board of Directors
David Berglund and Jake Doran appointed as new Board members
Appointment of Kelly Hnat as the IRISS Forum Vice President
The IRISS Board of Directors is pleased to announce the appointment of Kelly Hnat as the IRISS Forum VP.
Appointment of Sue Metz as the IRISS Forum CEO
The IRISS Board of Directors are pleased to announce the appointment of Sue Metz as the IRISS Forum CEO.
Webinar - January 9th: The EU eAF and the integration with SPOR
Don’t miss this month’s webinar on January 9th. The EU eAF and the integration with SPOR]
Join the IRISS Forum at the DIA RSIDM conference in February!
IRISS will have a booth and will gather for lunch on Tuesday, Feb. 6th. The luncheon is a great opportunity to put a face to the voices you’ve been hearing on the topic group calls and webinars.
IRISS publishes the results of survey on IDMP
The results of an industry survey undertaken during August 2017 is published. The IRISS IDMP Topic Group is a very active group and includes numerous IDMP experts, some very experienced sponsor companies and several vendors. The survey results are being made public to encourage other companies and individuals to join IRISS.
FDA Extends Compliance Date for Submitting DMFs in eCTD format
The FDA extended the compliance date for submitting DMF’s in eCTD format to May 5, 2018. See the FDA guidance document for additional information on the compliance date and FDA’s Drug Master File page for additional information on DMFs.
LinkedIn IRISS Forum Revitalization
LinkedIn provides a social media platform to share information across larger domains beyond the current IRISS Membership. The IRISS-Forum LinkedIn page is used to post notifications for events, webinars, announcements, and networking for followers. IRISS-Forum topic group meeting minutes, dial-in information, and records remain on the IRISS website and are accessible by members only. However, information posted to the LinkedIn IRISS-Forum page may be shared throughout social media.
If you are an IRISS member, and you would like to have an announcement published to the LinkedIn IRISS-Forum page, please send an email to [email protected].
IRISS publishes the results of readiness surveys for IDMP
The results of two surveys undertaken during August 2016 are published – an industry survey and a vendor survey. The IRISS IDMP Topic Group is a very active group and includes numerous IDMP experts, some very experienced sponsor companies and several vendors. The survey results are being made public to encourage other companies and individuals to join IRISS.
EU Harmonised Technical eCTD Guidance Updated
EU Harmonised technical eCTD guidance v 4.0 posted – with Redaction Proposal Document Package and UUID in the envelope. Click Here
FDA posts eCTD v4.0 Module 1 Implementation Package
FDA posts eCTD v4.0 Module 1 Implementation Package to coincide with ICH eCTD 4.0 Step 4 IG
ICH Publishes eCTD 4.0 Step 4
The ICH M8 Expert Working Group (EWG) has published the eCTD v4.0 Step 4 Implementation Guide and related files.
EU Releases new eCTD validation criteria – Version 6.0
EU Releases new eCTD validation criteria – Version 6.0 – updated for module 1 v3.0.
EMA: eCTD Mandatory Format for ASMF Submissions for Human Medicines as of July 1, 2016
From 1 July 2016, the use of the eCTD format for all ASMF submissions for human use in the centralised procedure will become mandatory.
EMA eCTD Validation Criteria 6.0
New validation criteria posted for public comment.The changes in the validation criteria relate mainly to the updated EU Module 1 eCTD Specification v.3.0 to come into force 1 July 2016 and Mandatory from 1 October 2016.
FDA Issued New eCTD Technical Conformance Guide
The guide provides specifications, recommendations, and general considerations on how to submit eCTD – based electronic submissions to CDER or CBER. It covers the electronic submission of INDs, NDAs, ANDAs, BLAs, and master files.
ICH Recommends DOCX as a Submission File Format
ICH Recommends DOCX as a Submission File Format. DOCX is an ISO standard and has the ability to contain custom embedded XML elements making it suitable for the submission of structured information. It is the default file format of MS Word.
EU eCTD M1 Draft Specs v3.0 for Public Consultation
A draft EU eCTD Module 1 v3.0 specification was issued by the EMA on 24-Jul-2015 and is open for Public Consultation.
TGA Australia - Paper Dossiers are no Longer Required to Accompany eCTD
Prescription medicine sponsors can now submit dossiers to the TGA in the electronic Common Technical Document (eCTD) format.
Paper dossiers are no longer required to accompany eCTD formatted submissions, following the success of the pilot programme between January and June 2015.